BSE Live
Apr 15, 16:00Prev. Close
10753.65
Open Price
10500.00
Bid Price (Qty.)
10530.00 (3)
Offer Price (Qty.)
10753.65 (48)
NSE Live
Apr 15, 15:59Prev. Close
10732.60
Open Price
10310.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
10732.60 (91)
Cash Flow of GlaxoSmithKline Consumer Healthcare (in Rs. Cr.) | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 982.80 | 700.10 | 656.68 | 1,055.40 | 889.14 | |
Net CashFlow From Operating Activities | 671.07 | 723.04 | 602.97 | 572.35 | 611.47 | |
Net Cash Used In Investing Activities | -335.06 | -446.45 | -602.40 | -156.88 | 330.69 | |
Net Cash Used From Financing Activities | -376.80 | -363.40 | -361.33 | -279.19 | -222.15 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -40.78 | -86.81 | -360.75 | 136.29 | 720.00 | |
Cash And Cash Equivalents Begin of Year | 614.10 | 700.91 | 1,061.67 | 925.38 | 205.38 | |
Cash And Cash Equivalents End Of Year | 573.32 | 614.10 | 700.91 | 1,061.67 | 925.38 |
01.02.2022
Storyboard18 | Paracetamol brand wars: Is Dolo rival Crocin feeling the chills?
27.02.2020
Chandigarh NCLT nod for HUL, GlaxoSmithKline Consumer Healthcare merger deal
07.02.2020
GlaxoSmith Con Standalone December 2019 Net Sales at Rs 1,158.86 crore, up 3.76% Y-o-Y
07.08.2019
Hold GlaxoSmithKline Consumer Healthcare target of Rs 7931: Sharekhan
07.02.2020
GlaxoSmith Con Standalone December 2019 Net Sales at Rs 1,158.86 crore, up 3.76% Y-o-Y
06.02.2020
02.08.2019
GlaxoSmith Con Standalone June 2019 Net Sales at Rs 1,194.32 crore, up 7.87% Y-o-Y
01.08.2019
10.07.2019
GSK Consumer Q1 PAT seen up 15.6% YoY to Rs. 231.8 cr: ICICI Direct
15.04.2019
GSK Consumer Q4 PAT seen up 10.1% YoY to Rs. 233.1 cr: ICICI Direct
08.04.2019
GSK Consumer Q4 PAT seen up 15.7% YoY to Rs. 245.1 cr: Kotak
16.01.2019
GlaxoSmithKline Consumer Healthcare Q3 PAT seen up 17.1% YoY to Rs. 191.6 cr: Prabhudas Lilladher